BASKHANBIO PHARMA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,790 KRW | 0.00% |
|
-3.00% | -0.15% |
| Current month | -10.66% | ||
| 1 month | -14.05% |
| 1 week | -3.00% | ||
| Current month | -10.66% | ||
| 1 month | -14.05% | ||
| 3 months | +8.81% | ||
| 6 months | +6.59% | ||
| Current year | -0.15% |
1 week
6 210.00
6 970.00
1 month
6 210.007 600.00
Current year
5 630.008 200.00
1 year
5 310.009 200.00
3 years
4 645.0013 850.00
5 years
4 645.0013 850.00
10 years
4 645.0013 850.00
| Managers | Title | Age | Since |
|---|---|---|---|
Beop-Pyo Lee
CEO | Chief Executive Officer | 59 | 15-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Beop-Pyo Lee
CEO | Chief Executive Officer | 59 | 15-10-31 |
BaskhanBio Pharma Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is engaged in the manufacture and sale of antipyretic analgesic anti-inflammatory drugs, digestive system drugs, central nervous system drugs, nutritional supplements and other pharmaceuticals. In addition, the Company is engaged in the sale of medical devices and health functional foods.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -0.15% | 34.91M | |
| +38.51% | 727B | |
| +33.05% | 599B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +16.00% | 243B | |
| +8.09% | 205B | |
| -5.77% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- A354390 Stock
